Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,857,564 papers from all fields of science
Search
Sign In
Create Free Account
TNFRSF10D gene
Known as:
TRAIL RECEPTOR WITH A TRUNCATED DEATH DOMAIN
, DECOY RECEPTOR 2
, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Ischemic Preconditioning Upregulates Decoy Receptors to Protect SH-SY5Y Cells from OGD Induced Cellular Damage by Inhibiting TRAIL Pathway and Agitating PI3K/Akt Pathway
Wei Jin
,
Wei Xu
,
Xiao-xiao Zhang
,
Chuan-cheng Ren
Molecular Neurobiology
2020
Corpus ID: 219947453
As ischemic preconditioning (IPC) represents a potential therapy against cerebral ischemia, the purpose of the present study is…
Expand
2019
2019
Differential gene methylation patterns in cancerous and non-cancerous cells
Katarzyna H. Kaminska
,
A. Białkowska
,
J. Kowalewski
,
Sui Huang
,
M. Lewandowska
Oncology Report
2019
Corpus ID: 162170720
Large-scale projects, such as The Cancer Genome Atlas (TCGA), Human Epigenome Project (HEP) and Human Epigenome Atlas (HEA…
Expand
2018
2018
Determination of normal expression patterns of CD86, CD210a, CD261, CD262, CD264, CD358, and CD361 in peripheral blood and bone marrow cells by flow cytometry.
R. C. Rudolf-Oliveira
,
M. Auat
,
+8 authors
M. Santos-Silva
Immunology Letters
2018
Corpus ID: 46765685
2016
2016
Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors. EVIDENCE FOR THE ROLE OF REACTIVE OXYGEN SPECIES AND JNK.
S. Prasad
,
V. Yadav
,
R. Kannappan
,
B. Aggarwal
Journal of Biological Chemistry
2016
Corpus ID: 6106929
Discovery of the molecular targets of traditional medicine and its chemical footprints can validate the use of such medicine. In…
Expand
Highly Cited
2015
Highly Cited
2015
Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients
Zibo Li
,
Xinwu Guo
,
+11 authors
Jun Wang
Breast Cancer Research and Treatment
2015
Corpus ID: 13009163
Gene-specific methylation alterations in breast cancer have been suggested to occur early in tumorigenesis and have the potential…
Expand
2015
2015
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB
M. Anees
,
P. Horák
,
+8 authors
M. Krainer
Leukemia and Lymphoma
2015
Corpus ID: 27844800
Abstract This study investigated expression profiles of tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL…
Expand
2013
2013
Expression of TRAIL and its receptors DR5 and DcR2 in orthodontic tooth movement.
V. Cardile
,
G. Musumeci
,
+4 authors
C. Loreto
Histology and Histopathology
2013
Corpus ID: 22083815
BACKGROUND TRAIL is a transmembrane protein that induces apoptosis in various tissues including alveolar bone. Its in vitro…
Expand
2008
2008
Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer.
M. Hornstein
,
M. Hoffmann
,
+5 authors
W. Schulz
Cancer Genomics & Proteomics
2008
Corpus ID: 30703150
BACKGROUND Allelic losses on chromosome 8p are common in prostate carcinoma, but it is not known exactly how they contribute to…
Expand
2008
2008
Antitumor effects of soluble TRAIL in human hepatocellular carcinoma
H. Songqing
,
Chen Yan
,
+4 authors
Wang Shaofa
Journal of Huazhong University of Science and…
2008
Corpus ID: 21264469
SummaryThe therapeutic potential of soluble TRAIL (sTRAIL) in hepatocellular carcinoma (HCC) was studied. The expression of TRAIL…
Expand
Review
2005
Review
2005
Mammalian Dicer finds a partner
J. Rossi
EMBO Reports
2005
Corpus ID: 43669629
RNA interference (RNAi) is a complex process that uses small RNAs of 21–23 nucleotides to guide sequence‐specific silencing of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE